Skip to content
OpenCapital
Get started

SELLAS Life Sciences Group, Inc. SLS Q2 2025 earnings

Reported August 12, 2025 · Before market open

Diluted EPS-$0.07Beat by $0.01
EPS estimate-$0.08

Next report

Aug 11, 2026 (In 4 weeks)
EPS estimate-$0.05

Financials

Q2 2025

Income statement

See full
Operating income-$6.9M+9.8%
Net income-$6.6M+11.6%
EPS (diluted)-$0.07+46.2%

Balance sheet

See full
Cash & equivalents$25.3M+177%
Total debt$737.0K+6.5%
Total equity$26.1M+798%
Total assets$32.3M+114%

Cash flow

See full
Operating cash flow-$7.3M+24.3%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$176.61M+157%
Enterprise value$152.05M+152%

Returns & leverage

See full
Return on equity-180.7%-80.1pp
Debt / equity0×-0.2×
Current ratio4.9×+3.9×

Versus estimates

Diluted EPS

Q1 2026-$0.05Beat by $0.01Q4 2025-$0.05Beat by $0.01Q3 2025-$0.06Beat by $0.00
Q2 2025-$0.07Beat by $0.01
Q1 2025-$0.07Beat by $0.03Q4 2024-$0.08Beat by $0.03

Ask the moment SELLAS Life Sciences Group, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did SELLAS Life Sciences Group, Inc. report Q2 2025 earnings?
SELLAS Life Sciences Group, Inc. (SLS) reported Q2 2025 earnings on August 12, 2025 before market open.
What were SELLAS Life Sciences Group, Inc.'s Q2 2025 revenue and EPS?
SELLAS Life Sciences Group, Inc. reported diluted EPS of $-0.07 for Q2 2025.
Did SELLAS Life Sciences Group, Inc. beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.08 by $0.01.
How did SELLAS Life Sciences Group, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 46.2% from $-0.13.
Where can I find SELLAS Life Sciences Group, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001390478-25-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.